Committee Decisions
Committee List
- ASPH DTC
- Commissioning Intentions
- East Surrey CCG Medicines Programme Board
- East Surrey MOG
- Epsom St Helier NDAIG
- ESCCG sub-committee of North Place Alliance Clinical Strategy Committee (formerly Clinical Executive
- Guildford and Waverley MOG
- Medicines Optimisation Operational Group (MOOG)
- Not Set
- NW Surrey Medicines Optimisation Group
- Primary Care Medicines Optimisation Clinical reference Group (PCMOCRG)
- RSCH DTC
- Surrey & North West Sussex Area Prescribing Committee (formerly Prescribing Clinical Network)
- Surrey Downs CCG Prescribing Leads Meeting
- Surrey Downs MOG
- Surrey Heartlands Integrated Care System Area Prescribing Committee (APC)
- Surrey Heartlands Medicines Optimisation Board (MOB)
- Surrey Heartlands Medicines Safety Committee (MSC)
- Surrey Medicines Commissioners Group
- Surrey Priorities Committee
Decisions : Surrey Heartlands Medicines Optimisation Board (MOB)
Records returned : 7.
The Surrey Heartlands Integrated Care System Area Prescribing Committee have agreed Infatrini Peptisorb as a 3rd line high energy formula option for use in infants with malabsorption or intolerance of whole protein feeds.
Prescribe as 200ml
A BLUE (on specialist recommendation) Traffic Light Status was agreed
The Medicines Optimisation Board approved the updated primary care guidance for multi-professional prescribers.
Note: Multi-professional prescribing (MPP) was formerly referred to as “non-medical prescribing” and known as independent prescribing; however, this newer term reflects a wider number of healthcare professionals who can prescribe within their scope of practice once they have completed an approved education programme and is more accurate and inclusive. This term is increasingly being adopted by professional bodies including the Royal Pharmaceutical Society (RPS) who author the prescribing competency framework.
The Surrey Heartlands Integrated Care System Area Prescribing Committee agreed the reviewed and updated Psoriatic arthritis high cost immunomodulator treatment pathway
Admission to Hospital check-list (see document below)
This document can be used as a guide to assist care home staff to ensure all necessary information, medication and personal items are sent with a care home resident, when they are admitted to hospital.
It should be used in conjunction with other guidance or policies or specific requests from the admitting hospital. This list is not exhaustive and there may be other documents/items which should accompany the resident.
Hypertension / Blood Pressure Checks in Community Pharmacy.
Community Pharmacy Surrey & Sussex have produced a summary of the key features and differences between the BP+ (the locally commissioned service) and the Hypertensive Case Finding Service (Advanced National Service).
The summary of the two services can be found below
DO NOT prescribe in primary care.
This drug is recommended in the treatment of COVID-19 ONLY in line with NHSE commissioning policies which include detail on eligibility and exclusion criteria for:
- Non-hospitalised patients - Refer eligible patients from Surrey Heartlands and Frimley to the East Berkshire Primary Care Covid Medicine Delivery Unit.
- Hospitalised patients – Hospital treatment of those with acute Covid-19 illness OR with hospital onset Covid-19
DO NOT prescribe in primary care.
This drug is recommended in the treatment of COVID-19 ONLY in line with NHSE commissioning policies (links below) which include detail on eligibility and exclusion criteria for:
- Non-hospitalised patients - Refer eligible patients from Surrey Heartlands and Frimley to the East Berkshire Primary Care Covid Medicine Delivery Unit.
- Hospitalised patients – Hospital treatment of those with acute Covid-19 illness OR with hospital onset Covid-19